About FDA

Division of Hematology Products (DHP)

Director: Ann Farrell, M.D.
Deputy Director:  Edvardas Kaminskas, M.D.
Associate Deputy Director: Albert Deisseroth, M.D. 
Deputy Director of Safety: Barry Miller (Acting) 

Safety Reviewer: Qin Ryan
Safety Regulatory Project Manager: Diane Leaman
Associate Director of Labeling: Virginia Kwitkowski
CPMS: Theresa Carioti
CPMS: Amy Baird
Project Specialist: Jeimy Flournoy 

The Division of Hematology Products (DHP) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologic Licensing Applications (BLAs) for small molecule agents and biologics used in hematology.

  • The hematology products include those products used predominantly as therapeutic agents in malignant hematological and nonmalignant hematological conditions, such as the treatment of anemias, venous thromboembolism, and platelet disorders.

Mailing Address:

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Hematology Products
5901-B Ammendale Road
Beltsville, MD 20705-1266

Phone: (301) 796-7550
Fax: (301) 796-9845

Page Last Updated: 02/28/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English